Literature DB >> 6326584

Impaired energy utilization and Na-K-ATPase in diabetic peripheral nerve.

D A Greene, S A Lattimer.   

Abstract

Recent electrophysiological and biochemical evidence implicates altered peripheral nerve Na-K-ATPase activity in the nerve conduction impairment of acute experimental diabetes. Composite in vitro nerve energy utilization is seriously impaired by experimental diabetes, yet is not modulated directly by insulin action on peripheral nerve. Therefore, we hypothesized that the reduction in diabetic nerve energy utilization reflects impaired nerve Na-K-ATPase activity. The reduction in steady-state energy utilization in diabetic peripheral nerve is shown to be quantitatively equal to the ouabain-inhibitable fraction of respiration, a measure of Na-K-ATPase activity in peripheral nerve. Na-K-ATPase activity in diabetic (but not nondiabetic) endoneurial preparations is influenced by medium solute concentration. Furthermore, diabetic nerve Na-K-ATPase activity and sodium-dependent myo-inositol uptake are similarly affected by medium solute changes, suggesting that the nerve sodium gradient may limit intracellular myo-inositol uptake in diabetic nerve. Conversely, because reduced diabetic nerve myo-inositol content impairs nerve Na-K-ATPase, a possible pathophysiological cycle of progressively deranged myo-inositol metabolism and Na-K-ATPase function may exist in diabetic peripheral nerve.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326584     DOI: 10.1152/ajpendo.1984.246.4.E311

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Brain tryptophan uptake and sodium-potassium ATPase activity in long-term streptozotocin diabetic rats.

Authors:  G Atienza; M D Andres; E Rebolledo; M Aldegunde
Journal:  Neurochem Res       Date:  1992-03       Impact factor: 3.996

2.  Diabetes induced by streptozotocin causes reduced Na-K ATPase in the brain.

Authors:  S F Leong; T K Leung
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

3.  Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5' end of the aldose reductase gene.

Authors:  A E Heesom; A Millward; A G Demaine
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

4.  Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.

Authors:  D A Greene; S Chakrabarti; S A Lattimer; A A Sima
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

Review 5.  Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.

Authors:  D A Greene
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 6.  Bioenergetics in diabetic neuropathy: what we need to know.

Authors:  Lucy M Hinder; Andrea M Vincent; Charles F Burant; Subramaniam Pennathur; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2012-05       Impact factor: 3.494

7.  Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction.

Authors:  K Terata; L J Coppey; E P Davidson; J A Dunlap; D D Gutterman; M A Yorek
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

8.  The effect of age on energy metabolism and resistance to ischaemic conduction failure in rat peripheral nerve.

Authors:  P A Low; J D Schmelzer; K K Ward
Journal:  J Physiol       Date:  1986-05       Impact factor: 5.182

Review 9.  The management of diabetic neuropathy in CKD.

Authors:  Rodica Pop-Busui; Laurel Roberts; Subramaniam Pennathur; Mathias Kretzler; Frank C Brosius; Eva L Feldman
Journal:  Am J Kidney Dis       Date:  2009-12-30       Impact factor: 8.860

10.  Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.

Authors:  Jia-Ying Sung; Susanna B Park; Ya-Ting Liu; Natalie Kwai; Ria Arnold; Arun V Krishnan; Cindy S-Y Lin
Journal:  Diabetes       Date:  2012-04-20       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.